195 related articles for article (PubMed ID: 24492799)
21. Alpha-melanocyte stimulating hormone preserves islet graft survival through down-regulation of Toll-like receptors.
Jung EJ; Kim SC; Jeong SH; Lee JY; Han DJ
Transplant Proc; 2012 May; 44(4):1086-90. PubMed ID: 22564632
[TBL] [Abstract][Full Text] [Related]
22. Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways.
Vivot K; Langlois A; Bietiger W; Dal S; Seyfritz E; Pinget M; Jeandidier N; Maillard E; Gies JP; Sigrist S
PLoS One; 2014; 9(10):e107656. PubMed ID: 25343247
[TBL] [Abstract][Full Text] [Related]
23. Human Islets Have Fewer Blood Vessels than Mouse Islets and the Density of Islet Vascular Structures Is Increased in Type 2 Diabetes.
Brissova M; Shostak A; Fligner CL; Revetta FL; Washington MK; Powers AC; Hull RL
J Histochem Cytochem; 2015 Aug; 63(8):637-45. PubMed ID: 26216139
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic islet inflammation: an emerging role for chemokines.
Collier JJ; Sparer TE; Karlstad MD; Burke SJ
J Mol Endocrinol; 2017 Jul; 59(1):R33-R46. PubMed ID: 28420714
[TBL] [Abstract][Full Text] [Related]
25. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.
Kulak K; Westermark GT; Papac-Milicevic N; Renström E; Blom AM; King BC
Diabetologia; 2017 Aug; 60(8):1522-1533. PubMed ID: 28500395
[TBL] [Abstract][Full Text] [Related]
26. Islet inflammation: a unifying target for diabetes treatment?
Imai Y; Dobrian AD; Morris MA; Nadler JL
Trends Endocrinol Metab; 2013 Jul; 24(7):351-60. PubMed ID: 23484621
[TBL] [Abstract][Full Text] [Related]
27. Activation of the NLRP3 inflammasome complex is not required for stress-induced death of pancreatic islets.
Wali JA; Gurzov EN; Fynch S; Elkerbout L; Kay TW; Masters SL; Thomas HE
PLoS One; 2014; 9(11):e113128. PubMed ID: 25405767
[TBL] [Abstract][Full Text] [Related]
28. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
[TBL] [Abstract][Full Text] [Related]
29. β-Cell Dedifferentiation in Patients With T2D With Adequate Glucose Control and Nondiabetic Chronic Pancreatitis.
Sun J; Ni Q; Xie J; Xu M; Zhang J; Kuang J; Wang Y; Ning G; Wang Q
J Clin Endocrinol Metab; 2019 Jan; 104(1):83-94. PubMed ID: 30085195
[TBL] [Abstract][Full Text] [Related]
30. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
31. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
32. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.
Lawlor N; George J; Bolisetty M; Kursawe R; Sun L; Sivakamasundari V; Kycia I; Robson P; Stitzel ML
Genome Res; 2017 Feb; 27(2):208-222. PubMed ID: 27864352
[TBL] [Abstract][Full Text] [Related]
33. beta-Cell death during progression to diabetes.
Mathis D; Vence L; Benoist C
Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
[TBL] [Abstract][Full Text] [Related]
34. The NLRP3 inflammasome: a sensor for metabolic danger?
Schroder K; Zhou R; Tschopp J
Science; 2010 Jan; 327(5963):296-300. PubMed ID: 20075245
[TBL] [Abstract][Full Text] [Related]
35. Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.
Morris DL
Mol Endocrinol; 2015 Jul; 29(7):946-62. PubMed ID: 26001058
[TBL] [Abstract][Full Text] [Related]
36. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat.
Homo-Delarche F; Calderari S; Irminger JC; Gangnerau MN; Coulaud J; Rickenbach K; Dolz M; Halban P; Portha B; Serradas P
Diabetes; 2006 Jun; 55(6):1625-33. PubMed ID: 16731824
[TBL] [Abstract][Full Text] [Related]
37. The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3.
Tannahill GM; O'Neill LA
FEBS Lett; 2011 Jun; 585(11):1568-72. PubMed ID: 21565193
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
Ladefoged M; Buschard K; Hansen AM
APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the Inflammasome NLRP3 by Arglabin Attenuates Inflammation, Protects Pancreatic β-Cells from Apoptosis, and Prevents Type 2 Diabetes Mellitus Development in ApoE2Ki Mice on a Chronic High-Fat Diet.
Abderrazak A; El Hadri K; Bosc E; Blondeau B; Slimane MN; Büchele B; Simmet T; Couchie D; Rouis M
J Pharmacol Exp Ther; 2016 Jun; 357(3):487-94. PubMed ID: 27044804
[TBL] [Abstract][Full Text] [Related]
40. New hope for type 2 diabetics: targeting insulin resistance through the immune modulation of stem cells.
Zhao Y; Jiang Z; Guo C
Autoimmun Rev; 2011 Dec; 11(2):137-42. PubMed ID: 21964164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
